Patients often go without effective new treatments, especially in rare disease patient populations where profit potential is limited. | Contemp Clin Trials;32(2): 151-2, 2011 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Patients often go without effective new treatments, especially in rare disease patient populations where profit potential is limited.

Bloom, Bruce E.

Contemp Clin Trials ; 32(2): 151-2, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21238613

Subject(s)

Biomedical Research/economics; Rare Diseases/economics; Biomedical Research/legislation & jurisprudence; Biomedical Research/organization & administration; Drug Discovery/economics; Humans; Rare Diseases/therapy; United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rare Diseases / Biomedical Research Limits: Humans Country/Region as subject: America do norte Language: En Journal: Contemp Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2011 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rare Diseases / Biomedical Research Limits: Humans Country/Region as subject: America do norte Language: En Journal: Contemp Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2011 Document type: Article